Business Context and Reporting Period
This Form 6-K filing by Compugen Ltd. covers the month of May 2023. The report addresses the Company's status regarding Nasdaq listing compliance, specifically concerning the Minimum Bid Price Requirement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance and listing status rather than financial performance.
Material Changes
- Listing Transfer Approved: On May 2, 2023, Nasdaq approved the transfer of Compugen's shares from The Nasdaq Global Market to The Nasdaq Capital Market, effective May 4, 2023.
- Compliance Extension: Due to the transfer, Nasdaq granted a second 180-day compliance period to regain the $1.00 minimum bid price, extending the deadline to October 30, 2023.
- Trading Continuity: The transfer is not expected to impact trading; shares will continue to trade under the symbol "CGEN."
Outlook, Risks, and Management Commentary
Management intends to actively monitor compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price must reach at least $1.00 for 10 consecutive business days by October 30, 2023. The Company has notified Nasdaq of its intention to cure the deficiency, which may include effecting a reverse share split if necessary. The primary risk remains the potential loss of listing status if the bid price requirement is not met by the new deadline.
Investor Verification Checklist
- Verify the effective date of the transfer to The Nasdaq Capital Market (May 4, 2023).
- Monitor the daily closing bid price to ensure it meets the $1.00 threshold for 10 consecutive days before October 30, 2023.
- Watch for future announcements regarding a potential reverse share split.
- Confirm that trading continues uninterrupted under the symbol "CGEN."